$63,239,785
to ARCTURUS THERAPEUTICS, INC.
PROCURE A PANDEMIC INFLUENZA VACCINE (PANDFLU) AND A QUADRIVALENT SEASONAL INFLUENZA VACCINE (QSFLU)
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
What the model surfaced from this award
Procure pandemic and seasonal influenza vaccines for U.S. pandemic preparedness stockpiles.
Secures domestic vaccine supply capacity for pandemic response, reducing reliance on foreign manufacturers during health emergencies.
Signals sustained government demand for mRNA and viral vector vaccine manufacturing capacity; supports domestic production scale-up.
Reduces U.S. dependence on Chinese pharmaceutical supply chains for critical pandemic vaccines; strengthens domestic biotech resilience.
Generated by award_classification v2.0.0 via claude-haiku-4-5-20251001 on 2026-05-15. Cost: $0.002160.
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier CONT_AWD_75A50122C00007_7505_-NONE-_-NONE-.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.